Literature DB >> 11281179

Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?

T Sugiyama1, K Nishikawa, Y Komatsu, J Ishizuka, T Mizushima, A Kumagai, M Kato, N Saito, H Takeda, M Asaka, J W Freston.   

Abstract

Recent reports in the United States have found that fewer peptic ulcers are due to Helicobacter pylori than previously believed. The aim of this study is to determine if the declining prevalence of H. pylori infection in the general population can account for the apparent increase in the frequency of non-H. pylori ulcers. A total of 396 patients with peptic ulcer or ulcer scar were enrolled in this study. The pre-1950 population consisted of 149 patients with gastric ulcers and with 44 duodenal ulcers. The post-1950 population consisted of 96 patients with gastric ulcers and 107 with duodenal ulcers. The frequency of H. pylori-negative gastric ulcers was 5.4% in patients born before 1950 and 4.2% in patients born after 1950, and the frequency of H. pylori-negative duodenal ulcers was 0% and 1.9%, respectively. There are no statistical differences between the two populations in gastric and duodenal ulcers. H. pylori seropositivity was 74.9% in asymptomatic volunteers born before 1950 and 20.7% in those born after 1950 (P < 0.01) in the general population. The attributable risk of H. pylori infection in peptic ulcer diseases was not affected by the prevalence of H. pylori infection in the general population in Japan. This suggests that the apparent increase in frequency of non-H. pylori ulcers in the United States is not simply due to the declining prevalence of infection. Other explanations for non-H. pylori ulcers should be sought.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11281179     DOI: 10.1023/a:1005600831851

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking.

Authors:  J H Kurata; A N Nogawa
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

2.  Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified?

Authors:  S Jyotheeswaran; A N Shah; H O Jin; G D Potter; F V Ona; W Y Chey
Journal:  Am J Gastroenterol       Date:  1998-04       Impact factor: 10.864

3.  Risk factors of peptic ulcer disease: different impact of Helicobacter pylori in Dutch and Japanese populations?

Authors:  R J Schlemper; S D van der Werf; J P Vandenbroucke; I Biemond; C B Lamers
Journal:  J Gastroenterol Hepatol       Date:  1996-09       Impact factor: 4.029

Review 4.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

5.  Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan.

Authors:  S Ohara; M Kato; M Asaka; T Toyota
Journal:  J Gastroenterol       Date:  1998-02       Impact factor: 7.527

6.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

7.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

8.  Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.

Authors:  C J Hawkey; Z Tulassay; L Szczepanski; C J van Rensburg; A Filipowicz-Sosnowska; A Lanas; C M Wason; R A Peacock; K R Gillon
Journal:  Lancet       Date:  1998-09-26       Impact factor: 79.321

9.  Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium.

Authors:  M Chiba; N Ishii; T Ishioka; M Murata; O Masamune; T Sugiyama; A Yachi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

Review 10.  Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.

Authors:  R J Hopkins; L S Girardi; E A Turney
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  11 in total

1.  Maintenance therapy of gastroesophageal reflux disease.

Authors:  Akihito Nagahara; Mariko Hojo; Daisuke Asaoka; Sumio Watanabe
Journal:  Clin J Gastroenterol       Date:  2010-02-19

2.  Association between acute pancreatitis and peptic ulcer disease.

Authors:  Kang-Moon Lee; Chang-Nyol Paik; Woo Chul Chung; Jin Mo Yang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

3.  Hypopharyngeal multichannel intraluminal impedance leads to the promising outcome of antireflux surgery in Japanese population with laryngopharyngeal reflux symptoms.

Authors:  Takeshi Suzuki; Yosuke Seki; Yoshitaka Okamoto; Toshitaka Hoppo
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 4.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

5.  Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects.

Authors:  Hongyun Wang; Liwei Lang; Ning Ou; Ruihua Shi; Haitang Hu; Pei Hu; Ji Jiang
Journal:  Clin Drug Investig       Date:  2016-06       Impact factor: 2.859

Review 6.  Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors.

Authors:  Bjarni Thjodleifsson
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 7.  Epidemiology and clinical characteristics of GERD in the Japanese population.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2009-04-14       Impact factor: 7.527

8.  Has peptic ulcer disease changed during the past ten years in Korea? A prospective multi-center study.

Authors:  Hyun Joo Jang; Min Ho Choi; Woon Geon Shin; Kyung Ho Kim; Yong Woo Chung; Kyoung Oh Kim; Cheol Hee Park; Il Hyun Baek; Kwang Ho Baik; Sea Hyub Kae; Hak Yang Kim
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

9.  The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease.

Authors:  Hiroshi Shida; Yuzo Sakai; Hiroyuki Hamada; Tetsuo Takayama
Journal:  J Clin Biochem Nutr       Date:  2012-11-13       Impact factor: 3.114

10.  Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms.

Authors:  Seiji Arihiro; Tomohiro Kato; Kyoko Ito; Masayuki Saruta; Toshiki Nikami; Takeshi Suzuki; Hisao Tajiri
Journal:  J Clin Biochem Nutr       Date:  2011-12-07       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.